Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2013 000 152.6 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Ponatinib "Benzamid, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluormethyl)phenyl]" |
54 | Title of basic patent | TIGZ | BICYCLISCHE HETEROARYL-VERBINDUNGEN |
51 | IPC main class | ICM (ICMV) | C07D 487/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/4745 (2006.01), A61K 31/519 (2006.01), A61K 31/437 (2006.01), A61K 31/444 (2006.01), A61K 31/496 (2006.01), A61K 31/4985 (2006.01), A61K 31/5025 (2006.01), C07D 471/02 (2006.01), C07D 471/04 (2006.01) |
94 | Start of term of protection | LB | Dec 23, 2026 |
94 | End of term of protection | LE | Jul 3, 2028 |
22 | DE application date | DAT | Dec 13, 2013 |
| Date of publication of application for a certificate | OT | Mar 6, 2014 |
| Date of publication of grant of certificate | PET | Aug 7, 2014 |
71/73 | Applicant/owner | INH | Takeda Pharmaceuticals U.S.A., Inc., 500 Kendall Street, 02142 Cambridge, MA, US |
74 | Representative | VTR | WSL Patentanwälte Partnerschaft mbB, 65185 Wiesbaden, DE |
| Address for service | | WSL Patentanwälte Partnerschaft mbB, 65185 Wiesbaden, DE |
| Due date | FT FG | Dec 31, 2026 Annual fee for the 21st year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 60 2006 034 460.0 |
68 | EP file number of basic patent | GEAKZ | 06 84 5939.5 |
43 | Date of first publication | EVT | Mar 6, 2014 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/13/839/001-004 2013-07-01
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/13/839/001-004 2013-07-01
|
| Date of the first transfer into DPMAregister | EREGT | Mar 6, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 6, 2025 (Show all update days)(Hide all update days)- Mar 6, 2025
- Applicant/owner: changed
- Procedures: New applicant/owner details, New applicant/owner details, 05.03.2025: new
- Aug 14, 2024
- St.36: changed (technical change)
- Mar 22, 2024; Mar 24, 2022; Jul 16, 2019; Mar 16, 2017; Feb 9, 2017; Nov 24, 2016; Nov 9, 2016; Nov 3, 2016; Jul 11, 2015; Aug 7, 2014; Jul 4, 2014; Jun 3, 2014; May 6, 2014; Apr 24, 2014; Apr 23, 2014; Apr 12, 2014; Apr 11, 2014; Mar 18, 2014; Mar 14, 2014
- Historical data not available for this/these date(s)
- Mar 6, 2014
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 5, 2025 |
71/73 | Applicant/owner | INH | Takeda Pharmaceuticals U.S.A., Inc., 02142 Cambridge, MA, US |
71/73 | Previous applicant/owner | INHF | Ariad Pharmaceuticals, Inc., Cambridge, Massachusetts 02139-4234, US |
| Date of update of the procedure | REGT | Mar 6, 2025 |